📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Adrenomed

1.1 - Company Overview

Adrenomed Logo

Adrenomed

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical development focused on rescuing vascular integrity to save critically ill patients with limited treatment options, including the lead product candidate Adrecizumab, a first-in-class monoclonal antibody.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Adrenomed

T2 Biosystems Logo

T2 Biosystems

HQ: United States Website
  • Description: Provider of rapid, accurate infectious disease diagnostics, including the T2Dx Instrument, a fully automated system running tests directly from whole blood, the FDA-cleared T2Bacteria Panel for identifying sepsis-causing bacteria without blood culture, and T2Candida for detecting invasive candidiasis from whole blood.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full T2 Biosystems company profile →
Nabriva Therapeutics Logo

Nabriva Therapeutics

HQ: Austria Website
  • Description: Provider of innovative anti-infective agents to treat serious infections, including XENLETA (lefamulin) for adult CABP, IV and oral, FDA-approved; CONTEPO (fosfomycin) IV for complicated urinary tract infections, including acute pyelonephritis, active against multi-drug resistant strains; and BC-7013, a topical pleuromutilin candidate for Gram-positive infections, including uncomplicated skin and skin structure infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nabriva Therapeutics company profile →
Crucell Logo

Crucell

HQ: The Netherlands Website
  • Description: Provider of global biopharmaceutical vaccine development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crucell company profile →
NovaBay Pharmaceuticals Logo

NovaBay Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical eye care products, including Avenova Antimicrobial Lid and Lash Solution, Novawipes by Avenova, Avenova Lubricant Eye Drops, and Avenova Moist Heating Eye Compress, plus proprietary hypochlorous acid wound care solutions: NeutroPhase for cleansing and irrigating wounds (China) and PhaseOne for cleansing post-surgical wounds (US, professional use).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NovaBay Pharmaceuticals company profile →
Affinium Pharmaceuticals Logo

Affinium Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical research and development focused on novel anti-infective medicines, advancing FASII antibacterial programs as a new antibiotic franchise with potential for multiple products targeting the FASII pathway, supported by a broad base of long-term intellectual property.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affinium Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Adrenomed

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Adrenomed

2.2 - Growth funds investing in similar companies to Adrenomed

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Adrenomed

4.2 - Public trading comparable groups for Adrenomed

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Adrenomed

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Adrenomed

What does Adrenomed do?

Adrenomed is a provider of clinical-stage biopharmaceutical development focused on rescuing vascular integrity to save critically ill patients with limited treatment options, including the lead product candidate Adrecizumab, a first-in-class monoclonal antibody.

Who are Adrenomed's competitors?

Adrenomed's competitors and similar companies include T2 Biosystems, Nabriva Therapeutics, Crucell, NovaBay Pharmaceuticals, and Affinium Pharmaceuticals.

Where is Adrenomed headquartered?

Adrenomed is headquartered in Germany.

How many employees does Adrenomed have?

Adrenomed has 1,000 employees 🔒.

When was Adrenomed founded?

Adrenomed was founded in 2010 🔒.

What sector and industry vertical is Adrenomed in?

Adrenomed is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adrenomed

Who are the top strategic acquirers in Adrenomed's sector and industry

Top strategic M&A buyers and acquirers in Adrenomed's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adrenomed?

Top strategic M&A buyers groups and sectors for Adrenomed include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adrenomed's sector and industry vertical

Which are the top PE firms investing in Adrenomed's sector and industry vertical?

Top PE firms investing in Adrenomed's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adrenomed's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adrenomed's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adrenomed's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adrenomed include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adrenomed's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adrenomed?

The key public trading comparables and valuation benchmarks for Adrenomed include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adrenomed for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adrenomed with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adrenomed's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adrenomed with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adrenomed's' sector and industry vertical?

Access recent funding rounds and capital raises in Adrenomed's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Adrenomed